High throughout technologies has already significantly revolutionized fields such as genomics, proteomics, and drug discovery and formulation. This technology can similarly revolutionize the development of biomaterials for tissue engineering applications. A fundamental component of this proposal is to apply and advance our fully automated, high throughput discovery methods to push hESC tissue engineering closer towards clinical applications. Two key remaining limitations of existing hESC and iPSC methods are 1) the low efficiency and long time associated with stem cell differentiation into functional cell types such as chondrocytes and osteoblasts, and 2) suboptimal performance (e.g. mechanical properties, biocompatibility) of existing degradable materials used for tissue engineering. As such, we propose to develop both high throughput strategies to rapidly optimize the production of homogenous populations of key cell populations and degradable biomaterials that provide for improved cellular performance and low inflammation. Accordingly our specific aims are:
Aim1. Develop efficient, rapid methods to differentiate human embryonic stem cells (hESCs) and induced pluripotent stem cells (iPSCs) into homogenous populations of craniofacial cells. We will use high-throughput approaches on hESC and iPSC cells to identify the optimal combinations of soluble (growth factor and small molecules), and insoluble factors (synthetic polymer surfaces) capable of committing ES cells to craniofacial precursor cells and fully committed osteogenic and chondrogenic cells.
Aim 2 : Develop biodegradable, non-inflammatory and mechanically appropriate 3D scaffold systems that can effectively deliver craniofacial cells to the site of injury. High-throughput libraries of hyaluronic acid (cartilage) and poly(2-amino ester) (bone) polymers will be synthesized and assessed for ability to form gels or solid porous scaffolds, respectively. Favorable materials will then be evaluated for either chondrocyte or bone cell compatibility.
Aim 3 : Assess performance of tissue engineered constructs developed in Aim 1 and 2 to generate cartilage and bone in vivo. Small animal model will be used to test osteogenesis in a cranial critical sized defect, while chondrogenesis will be evaluated subcutaneously.

Public Health Relevance

We believe that this technology can similarly revolutionize the development of biomaterials for tissue engineering applications. A fundamental component of this proposal is to apply and advance our fully automated, high throughput discovery methods to push hESC and iPSC tissue engineering closer towards craniofacial clinical applications.

Agency
National Institute of Health (NIH)
Institute
National Institute of Dental & Craniofacial Research (NIDCR)
Type
Research Project (R01)
Project #
5R01DE016516-09
Application #
8403394
Study Section
Musculoskeletal Tissue Engineering Study Section (MTE)
Program Officer
Lumelsky, Nadya L
Project Start
2005-04-01
Project End
2015-01-31
Budget Start
2013-02-01
Budget End
2014-01-31
Support Year
9
Fiscal Year
2013
Total Cost
$379,208
Indirect Cost
$153,489
Name
Massachusetts Institute of Technology
Department
Internal Medicine/Medicine
Type
Schools of Arts and Sciences
DUNS #
001425594
City
Cambridge
State
MA
Country
United States
Zip Code
02139
Bogorad, Roman L; Yin, Hao; Zeigerer, Anja et al. (2014) Nanoparticle-formulated siRNA targeting integrins inhibits hepatocellular carcinoma progression in mice. Nat Commun 5:3869
Hook, Andrew L; Chang, Chien-Yi; Scurr, David J et al. (2014) Thermally switchable polymers achieve controlled Escherichia coli detachment. Adv Healthc Mater 3:1020-5
Dong, Yizhou; Eltoukhy, Ahmed A; Alabi, Christopher A et al. (2014) Lipid-like nanomaterials for simultaneous gene expression and silencing in vivo. Adv Healthc Mater 3:1392-7
Eltoukhy, Ahmed A; Chen, Delai; Alabi, Christopher A et al. (2013) Degradable terpolymers with alkyl side chains demonstrate enhanced gene delivery potency and nanoparticle stability. Adv Mater 25:1487-93
Gu, Minghao; Yildiz, Hasan; Carrier, Rebecca et al. (2013) Discovery of low mucus adhesion surfaces. Acta Biomater 9:5201-7
Dang, Tram T; Thai, Anh V; Cohen, Joshua et al. (2013) Enhanced function of immuno-isolated islets in diabetes therapy by co-encapsulation with an anti-inflammatory drug. Biomaterials 34:5792-801
Hook, Andrew L; Chang, Chien-Yi; Yang, Jing et al. (2013) Discovery of novel materials with broad resistance to bacterial attachment using combinatorial polymer microarrays. Adv Mater 25:2542-7
Sharei, Armon; Zoldan, Janet; Adamo, Andrea et al. (2013) A vector-free microfluidic platform for intracellular delivery. Proc Natl Acad Sci U S A 110:2082-7
Heller, Daniel A; Levi, Yair; Pelet, Jeisa M et al. (2013) Modular 'click-in-emulsion' bone-targeted nanogels. Adv Mater 25:1449-54
Chertok, Beata; Webber, Matthew J; Succi, Marc D et al. (2013) Drug delivery interfaces in the 21st century: from science fiction ideas to viable technologies. Mol Pharm 10:3531-43

Showing the most recent 10 out of 46 publications